DCOY Latest Press Releases

-- November 10, 2026 --

Decoy Therapeutics Named 'R&D Solution of the Year' in 2026 BioTech Breakthrough Awards Globe Newswire 9:47 AM

-- November 3, 2026 --

Decoy Therapeutics Provides Third Quarter 2026 Business Update Globe Newswire 7:15 AM

-- September 30, 2026 --

Decoy Therapeutics to Present at The Small Cap Showcase Globe Newswire 8:30 AM

-- September 29, 2026 --

Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program PRNewswire 7:30 AM

-- September 22, 2026 --

Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release PRNewswire 6:15 PM

/C O R R E C T I O N -- Decoy Therapeutics, Inc/ PRNewswire 2:04 PM

Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules PRNewswire 12:51 PM

Today's Best Stocks to Watch: Weight-Loss Wars, Biotech and Critical Minerals Globe Newswire 10:31 AM

Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding PRNewswire 7:31 AM

-- August 3, 2026 --

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform PRNewswire 9:00 AM

-- July 27, 2026 --

Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV Platform into High Consequence Global Health Threats PRNewswire 9:00 AM

-- July 15, 2026 --

Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors PRNewswire 9:25 AM

-- June 29, 2026 --

4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones Globe Newswire 9:50 AM

-- June 26, 2026 --

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing PRNewswire 8:12 PM

Market Data Delayed 15 Minutes